Sabra Health (Germany) Market Value
SBC Stock | EUR 17.58 0.13 0.74% |
Symbol | Sabra |
Sabra Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sabra Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sabra Health.
10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Sabra Health on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Sabra Health Care or generate 0.0% return on investment in Sabra Health over 30 days. Sabra Health is related to or competes with Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, Talanx AG, 2G ENERGY, and NorAm Drilling. As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled Nu... More
Sabra Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sabra Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sabra Health Care upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.95 | |||
Information Ratio | 0.1028 | |||
Maximum Drawdown | 8.26 | |||
Value At Risk | (3.09) | |||
Potential Upside | 3.45 |
Sabra Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sabra Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sabra Health's standard deviation. In reality, there are many statistical measures that can use Sabra Health historical prices to predict the future Sabra Health's volatility.Risk Adjusted Performance | 0.1404 | |||
Jensen Alpha | 0.2931 | |||
Total Risk Alpha | 0.0233 | |||
Sortino Ratio | 0.0939 | |||
Treynor Ratio | 3.66 |
Sabra Health Care Backtested Returns
Sabra Health appears to be very steady, given 3 months investment horizon. Sabra Health Care owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sabra Health Care, which you can use to evaluate the volatility of the company. Please review Sabra Health's Coefficient Of Variation of 567.42, risk adjusted performance of 0.1404, and Semi Deviation of 1.58 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sabra Health holds a performance score of 12. The entity has a beta of 0.0827, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sabra Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sabra Health is expected to be smaller as well. Please check Sabra Health's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to make a quick decision on whether Sabra Health's existing price patterns will revert.
Auto-correlation | 0.04 |
Virtually no predictability
Sabra Health Care has virtually no predictability. Overlapping area represents the amount of predictability between Sabra Health time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sabra Health Care price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Sabra Health price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.04 | |
Spearman Rank Test | -0.61 | |
Residual Average | 0.0 | |
Price Variance | 0.1 |
Sabra Health Care lagged returns against current returns
Autocorrelation, which is Sabra Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sabra Health's stock expected returns. We can calculate the autocorrelation of Sabra Health returns to help us make a trade decision. For example, suppose you find that Sabra Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Sabra Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sabra Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sabra Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sabra Health stock over time.
Current vs Lagged Prices |
Timeline |
Sabra Health Lagged Returns
When evaluating Sabra Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sabra Health stock have on its future price. Sabra Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sabra Health autocorrelation shows the relationship between Sabra Health stock current value and its past values and can show if there is a momentum factor associated with investing in Sabra Health Care.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.